查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1919406

農業合成生物學市場按產品類型、技術平台、配方、應用領域和最終用戶分類－2026年至2032年全球預測

Agriculture Synthetic Biology Market by Product Type, Technology Platform, Formulation, Application Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，農業合成生物學市場價值將達到 124.9 億美元，到 2026 年將成長至 131.5 億美元，到 2032 年將達到 183.2 億美元，複合年成長率為 5.61%。

關鍵市場統計數據
基準年 2025 124.9億美元
預計年份：2026年 131.5億美元
預測年份 2032 183.2億美元
複合年成長率 (%) 5.61%

技術、監管變革和商業化三者融合，共同開啟了農業合成生物學的新時代，這將重新定義農業生產力和韌性。

農業合成生物學正在重塑相關人員對全球糧食和纖維系統生產力、永續性和韌性的認知。基因編輯、通路工程和生物製藥的進步，使得在微生物學、植物生理學和生態學交叉領域發揮作用的解決方案成為可能。這些技術進步伴隨著新的交付模式、合作商業化模式以及不斷變化的監管環境，而這需要開發人員、生產者和政策制定者之間的跨學科合作。

識別技術採納、商業化模式和交付系統的關鍵轉折點，這些轉折點將重新定義農業合成生物學價值鏈。

農業合成生物學領域正經歷變革性的轉變，涵蓋技術成熟、商業化模式和生態系統整合等各個面向。精準基因編輯、模組化合成途徑和標靶RNA干擾等技術平台正從實驗室展示走向田間檢驗產品，從而改變現有的採購和應用模式。研發人員正將嚴謹的工程技術與農藝檢驗相結合，並促進生物技術公司、種子企業和大型種植者之間的合作，以在保持農藝性能的同時加速技術的應用。

評估美國2025年實施的累積關稅如何重塑農業合成生物學領域的供應鏈、合作動態和商業化路徑。

2025年美國關稅政策為農業合成生物學相關的國際投入、合作研究和跨境商業化帶來了新的摩擦。對原料、生物加工設備和某些半成品的關稅，使依賴全球供應鏈獲取酵素、生物反應器和製劑成分的製造商的採購流程變得更加複雜。這迫使供應鏈相關人員重新評估其籌資策略，盡可能優先考慮近岸外包，並評估庫存緩衝方法以維持生產的連續性。

根據產品類別、應用、技術平台、最終用戶和配方選擇等方面的細分，確定策略要務，以指導投資和商業化決策。

基於細分市場的洞察揭示了產品、應用、技術、終端用戶和配方方面的差異如何影響農業合成生物學領域的研發重點和商業化策略。根據產品類型，相關人員應區分以下幾類：生物肥料（包括固氮菌株、溶磷菌株和鉀動員菌株）、生質燃料（例如生物柴油、生質乙醇生物膜、生質塑膠）、生物農藥（包括生化、微生物和RNAi方法）以及酵素（例如澱粉酶、纖維素酶和蛋白酶）。產品類型都有不同的研發週期、監管節點和通路，因此需要針對每類產品製定單獨的上市計劃。

描繪了區域監管趨勢、行業能力和農業優先事項將如何影響美洲、歐洲、中東和非洲以及亞太地區的採用和商業化路徑。

區域洞察揭示了需求促進因素、法規結構和行業能力在不同地區的差異，以及這些差異如何影響開發商和投資者的策略重點。在美洲，成熟的農業供應鏈和充滿活力的私人投資群體正在推動生物製劑的快速初步試驗和商業化，這得益於其在發酵、酵素生產和精準應用技術方面的深厚實力。政策辯論和州級獎勵也影響生物製劑的推廣路徑，基因編輯解決方案的接受度存在區域差異，並且越來越重視將永續性指標納入採購流程。

檢驗了平台專業化、商業化夥伴關係以及生產規模化如何為農業合成生物學領域的公司創造差異化的競爭優勢。

農業合成生物學領域的公司層面發展趨勢呈現出平台專家、垂直整合型老牌企業和敏捷型新創公司並存的局面，這些公司致力於將研發成果轉化為實際應用。主要企業強調模組化技術Start-Ups，以實現產品平臺的快速迭代；而新參與企業則傾向於專注於小眾但影響深遠的應用案例，以驗證其有效性並建立市場影響力。產品開發商與以分銷為導向的農業供應商之間的策略聯盟，能夠利用既有通路和種植者關係，加速產品進入市場。

為了加速合成生物學的採用並降低商業化風險，應優先考慮監管前瞻性、配方主導的產品設計、策略夥伴關係和供應鏈韌性。

產業領導者應採取切實可行的優先事項，協調研發、監管規劃和商業執行，以加速產品推廣並降低風險。首先，在產品開發初期就應考慮監管合規和管理，以縮短核准時間並建立市場信心。儘早與監管機構溝通並制定透明的環境監測計劃，將有助於提高田間試驗的可靠性，並促進後續的註冊流程。其次，在菌株和分子開發的同時，推動製劑創新，以確保產品設計能體現給藥性能和農場實際應用價值。

本分析採用混合方法分析方法，結合了初步訪談、文獻綜述、專利和監管審查以及專家檢驗，以確保得出可靠的結論。

本分析的調查方法結合了原始質性資料、二手文獻綜述和多學科專家檢驗，從而得出可靠且可操作的見解。原始數據包括對技術開發人員、配方科學家、農藝師、供應鏈營運人員和監管專家的結構化訪談。這些訪談提供了研發瓶頸、田間檢驗重點和商業化限制的第一手觀點，為跨產品類型和應用的主題分析奠定了基礎。

總之，我們認為，將平台開發、製劑科學、監管事務和商業化夥伴關係結合的策略將決定農業合成生物學的成功。

本結論整合了報告的診斷和諮詢兩方面內容。農業合成生物學正從概念驗證創新階段邁向商業性化解決方案階段，需要跨技術、配方、監管和市場管道的整合策略。能夠將平台功能與明確的應用需求相匹配、投資於可擴展的生產和供應系統、並積極與監管機構和農場層面的相關人員互動以建立信譽並減少推廣障礙的機構，將更有可能取得成功。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的農業合成生物學市場

  • 生物肥料
    • 固氮作用
    • 磷酸鹽溶解
    • 鉀溶解
  • 生質燃料
    • 生質柴油
    • 生質乙醇
  • 生醫材料
    • 生物膜
    • 生質塑膠
  • 生物農藥
    • 生化產品
    • 微生物製劑
    • 基於RNAi的
  • 酵素
    • 澱粉酶
    • 纖維素酶
    • 蛋白酶

9. 按技術平台分類的農業合成生物學市場

  • Crispr/Cas
    • 基地編輯
    • Cas12
    • Cas9
  • 代謝工程
    • 通量分析
    • 路線最佳化
  • RNAi干擾
    • miRna
    • siRNA
  • 合成路線
    • 模組化生物合成
    • 通路組裝

10. 按配方分類的農業合成生物學市場

  • 封裝
    • 微膠囊化
    • 奈米封裝
  • 液體
    • 水溶液
    • 乳液
  • 粉末
    • 乾顆粒
    • 可水合粉末

第11章 按應用領域分類的農業合成生物學市場

  • 動物健康
    • 益生菌
    • 治療性蛋白質
  • 作物保護
    • 疾病管制
    • 害蟲防治
    • 除草
  • 促進生長
    • 根系發育
    • 抗壓能力
    • 產量提升
  • 土壤修復
    • 重金屬去除
    • 有機污染物的分解

12. 按最終用戶分類的農業合成生物學市場

  • 農業生物技術公司
    • 現有公司
    • Start-Ups公司
  • 商業農場
    • 大規模
    • 小規模農戶
  • 研究所
    • 政府研究機構
    • 大學

第13章 農業合成生物學市場：按地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 農業合成生物學市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國農業合成生物學市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國農業合成生物學市場

第17章 中國農業合成生物學市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AgBiome, Inc.
  • Agragene, Inc.
  • Arzeda Corporation
  • BASF SE
  • Bayer AG
  • Benson Hill, Inc.
  • BioConsortia, Inc.
  • Calysta, Inc.
  • Caribou Biosciences, Inc.
  • Conagen Inc.
  • Corteva, Inc.
  • DuPont de Nemours, Inc.
  • EVOLVE Biosystems, Inc.
  • Ginkgo Bioworks, Inc.
  • Inari Agriculture, Inc.
  • Indigo Agriculture, Inc.
  • KWS SAAT SE & Co. KGaA
  • Limagrain Group
  • Pairwise Companies, Inc.
  • Pivot Bio, Inc.
  • Syngenta AG
  • Synthace Ltd.
  • Zymergen Inc.
Product Code: MRR-F14BA1B3430B

The Agriculture Synthetic Biology Market was valued at USD 12.49 billion in 2025 and is projected to grow to USD 13.15 billion in 2026, with a CAGR of 5.61%, reaching USD 18.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.49 billion
Estimated Year [2026] USD 13.15 billion
Forecast Year [2032] USD 18.32 billion
CAGR (%) 5.61%

Framing the era of agricultural synthetic biology where technology, regulatory evolution, and commercialization converge to redefine productivity and resilience

Agricultural synthetic biology is reshaping the way stakeholders conceive of productivity, sustainability, and resilience across global food and fiber systems. Advances in gene editing, pathway assembly, and biologics formulation are enabling solutions that operate at the interface of microbiology, plant physiology, and agroecology. These technological strides are accompanied by new delivery formats, collaborative commercialization models, and an evolving regulatory landscape that requires multidisciplinary coordination between developers, growers, and policy makers.

This introduction frames the report's analytical focus: understanding how product innovation, application specificity, and platform choice are unlocking both near-term field-level improvements and longer-term shifts in supply chain structure. It highlights the imperative for industry participants to adopt integrated strategies that combine robust R&D pipelines with pragmatic deployment plans, stakeholder engagement, and adaptive risk management. The objective is to equip decision-makers with the context and clarity to prioritize investments and partnerships that yield measurable agronomic and environmental benefits while navigating compliance and market acceptance dynamics.

Identifying the pivotal shifts in technology adoption, commercialization models, and delivery systems that are redefining agricultural synthetic biology value chains

The landscape for agricultural synthetic biology is undergoing transformative shifts that span technology maturation, commercialization models, and ecosystem integration. Technology platforms such as precise gene editing, modular synthetic pathways, and targeted RNA interference are moving from laboratory demonstrations to field-validated products, which in turn changes incumbent procurement and deployment practices. Developers are converging engineering rigor with agronomic validation, fostering collaborations between biotech firms, seed companies, and large-scale growers to fast-track adoption while maintaining agronomic performance.

Concurrently, formulation science and delivery systems have advanced, enabling encapsulated and liquid biologics to achieve improved shelf life, targeted release, and compatibility with existing agronomic inputs. Investment patterns are shifting from single-product bets to platform-oriented portfolios that prioritize scalable manufacturing and regulatory traceability. These shifts also precipitate new partnerships between startups and established agricultural suppliers, creating hybrid go-to-market approaches that combine agility with channel reach. As a result, the sector is increasingly defined by systems-level integration rather than isolated product innovation, and by the need to demonstrate both field efficacy and supply-chain viability.

Assessing how the cumulative tariff measures introduced in the United States during 2025 have reshaped supply chains, collaboration dynamics, and commercialization pathways in agricultural synthetic biology

Recent tariff policies implemented by the United States in 2025 have introduced additional frictions across international inputs, collaborative research, and cross-border commercialization relevant to agricultural synthetic biology. Tariffs on feedstocks, bioprocessing equipment, and certain intermediate goods have increased procurement complexity for manufacturers that rely on global supply chains for enzymes, bioreactors, and formulation components. This has prompted supply chain actors to reassess sourcing strategies, prioritize nearshoring where feasible, and evaluate inventory buffering practices to maintain production continuity.

The cumulative impacts extend to collaborative research and licensing arrangements, where higher transaction costs can slow the movement of materials and technology between partners. Regulatory compliance and customs clearance have become more salient considerations, increasing the administrative burden on companies engaging in international field trials or multi-jurisdictional product registrations. In response, some organizations have accelerated diversification of supplier bases, intensified local supplier development efforts, and reconfigured manufacturing footprints to reduce exposure. For stakeholders, the imperative is to integrate tariff risk assessment into commercial planning and to pursue contractual protections and supply continuity mechanisms that preserve R&D momentum and market access.

Uncovering segmentation-driven strategy imperatives across product classes, application domains, technology platforms, end-users, and formulation choices to guide investment and commercialization decisions

Segmentation-driven insights reveal how product, application, technology, end-user, and formulation distinctions materially influence development priorities and commercialization strategies in agricultural synthetic biology. Based on Product Type, stakeholders must differentiate between Biofertilizers-encompassing Nitrogen Fixing, Phosphate Solubilizing, and Potassium Mobilizing strains-and Biofuels like Biodiesel and Bioethanol, as well as Biomaterials such as Biofilms and Bioplastics, Biopesticides spanning Biochemical, Microbials, and RNAi-based approaches, and Enzymes including Amylases, Cellulases, and Proteases. Each product class exhibits distinct R&D timelines, regulatory touchpoints, and distribution channels, which necessitates tailored go-to-market plans.

Based on Application Area, the focus ranges from Animal Health where Probiotics and Therapeutic Proteins address productivity and disease management, to Crop Protection targeting Disease Control, Insect Control, and Weed Control, as well as Growth Enhancement efforts emphasizing Root Development, Stress Tolerance, and Yield Improvement, and Soil Remediation activities focused on Heavy Metal Removal and Organic Pollutant Degradation. These application domains determine validation protocols, end-user adoption incentives, and environmental monitoring requirements. Based on Technology Platform, choices among Crispr/Cas variants such as Base Editing, Cas12, and Cas9, Metabolic Engineering techniques including Flux Analysis and Pathway Optimization, RNAi Interference approaches like miRNA and siRNA, and Synthetic Pathways methods such as Modular Biosynthesis and Pathway Assembly create differing IP considerations and development bottlenecks. Based on End User, the market navigates the needs of Agri Biotech Companies that range from Established firms to Startups, Commercial Farmers from Large Scale operators to Smallholder systems, and Research Institutions spanning Government Labs and Universities, each with unique procurement cycles and validation expectations. Based on Formulation, product performance is affected by Encapsulated formats including Microencapsulation and Nanoencapsulation, Liquid presentations as Aqueous or Emulsions, and Powder types such as Dry Granules and Wettable Powders, which influence logistics, on-farm handling, and application compatibility. Integrating these segmentation lenses clarifies where investment in analytics, regulatory strategy, and commercial partnerships will yield the most durable competitive advantage.

Mapping how regional regulatory dynamics, industrial capabilities, and agricultural priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization pathways

Regional insights illuminate how demand drivers, regulatory frameworks, and industrial capabilities vary across geographies and shape strategic priorities for developers and investors. In the Americas, mature agricultural supply chains and active private investment communities favor rapid piloting and commercialization of biologics, supported by substantial capacity in fermentation, enzyme production, and precision application technologies. Policy discourse and state-level incentives also influence adoption pathways, with varied acceptance for gene-edited solutions and an emphasis on integrating sustainability metrics into procurement.

In Europe, Middle East & Africa, regulatory rigor and consumer scrutiny around genetically modified and gene-edited agricultural products require careful engagement and transparent risk communication. Europe's regulatory frameworks and sustainability goals encourage solutions that demonstrate reduced chemical inputs and measurable environmental benefits, while parts of the Middle East and Africa present opportunities for resilience-focused interventions such as drought tolerance and soil remediation where climatic pressures are acute. In the Asia-Pacific region, dense food systems, diverse farm scales, and strong manufacturing ecosystems create a dynamic environment for both high-throughput product development and rapid adoption in commercial farming contexts. Governments across the region frequently support biotechnology innovation through funding and public-private partnerships, and proximity to large production clusters offers advantages for scaling manufacturing and distribution.

Examining how platform specialization, commercialization partnerships, and manufacturing scale-up create differentiated competitive advantages among companies in agricultural synthetic biology

Company-level dynamics in agricultural synthetic biology reflect a mix of platform specialists, vertically integrated incumbents, and agile startups that bridge discovery and field execution. Leading players emphasize modular technology stacks that enable rapid iteration across product pipelines, while newer entrants often concentrate on narrow, high-impact use cases to validate efficacy and build market traction. Strategic alliances between product developers and distribution-focused agricultural suppliers accelerate market entry by leveraging established channels and grower relationships.

Investment in manufacturing scalability and formulation R&D distinguishes companies that move beyond proof-of-concept toward reliable field deployment. Those that integrate regulatory strategy early, maintain transparent safety dossiers, and build robust stewardship programs tend to achieve broader acceptance among commercial farmers and institutional buyers. Intellectual property approaches vary from broad platform patents to focused trade secrets around strain engineering and encapsulation processes. The competitive landscape favors organizations that balance technical depth with pragmatic commercialization capabilities, and that invest in on-farm demonstration trials and multi-year agronomic datasets to reduce perceived adoption risk.

Prioritize regulatory foresight, formulation-led product design, strategic partnerships, and supply chain resilience to accelerate adoption and reduce commercialization risk in synthetic biology

Industry leaders should adopt a set of actionable priorities that align R&D, regulatory planning, and commercial execution to accelerate adoption and mitigate risk. First, embed regulatory and stewardship considerations at the outset of product development to shorten review timelines and build market trust. Early engagement with regulators and transparent environmental monitoring plans improve the credibility of field trials and ease later registration pathways. Second, pursue formulation innovation in parallel with strain or molecule development so that delivery performance and on-farm usability inform product design rather than being treated as an afterthought.

Third, design collaborative commercialization models that combine the agility of startups with the distribution reach of established agricultural suppliers; these partnerships can reduce channel friction and enhance farmer trial uptake. Fourth, diversify supply chains and prioritize regional manufacturing capabilities to insulate operations from tariff shocks and logistics disruptions. Fifth, invest in rigorous agronomic validation through multi-environment trials and independent third-party evaluations to create defensible efficacy claims. Finally, develop clear value-communication frameworks that translate technical benefits into farm-level economics and sustainability outcomes, making it easier for procurement teams and growers to adopt novel biological solutions.

Describing a mixed-methods analytical approach integrating primary interviews, literature synthesis, patent and regulatory review, and expert validation to ensure robust insights

The research methodology underpinning this analysis combines primary qualitative inputs, secondary literature synthesis, and cross-disciplinary expert validation to produce robust, actionable insights. Primary inputs include structured interviews with technology developers, formulation scientists, agronomists, supply chain operators, and regulatory specialists. These conversations provided first-hand perspectives on development bottlenecks, field validation priorities, and commercialization constraints that informed thematic analysis across product classes and applications.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, patent filings, and public corporate disclosures to triangulate technological trends and commercial behaviors. Wherever possible, the analysis prioritized primary evidence and authoritative sources, cross-checking claims to minimize bias. The findings were then validated through iterative consultations with independent subject-matter experts and practitioners who reviewed assumptions and recommended refinements. This mixed-methods approach ensured that conclusions reflect practical realities across laboratory development, formulation engineering, on-farm testing, and supply chain execution.

Concluding that integrated strategies across platform development, formulation science, regulatory engagement, and commercialization partnerships determine success in agricultural synthetic biology

The conclusion synthesizes the report's diagnostic and prescriptive strands: agricultural synthetic biology is transitioning from proof-of-concept innovation toward commercially viable solutions that require integrated strategies across technology, formulation, regulation, and market channels. Success will favor organizations that align platform capabilities with clear application needs, invest in scalable manufacturing and delivery systems, and proactively engage regulatory and farm-level stakeholders to build credibility and reduce adoption friction.

Looking forward, resilient commercialization will depend on the ability to demonstrate consistent field performance, articulate clear economic and environmental value, and to structure partnerships that bridge technical development with market access. Companies that combine rigorous agronomic validation with adaptive supply chain planning and transparent stewardship will be best positioned to capture long-term opportunities while managing operational and reputational risk. The industry's trajectory points toward systems-level solutions that integrate biological innovation into robust service models for growers, processors, and supply chain partners.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agriculture Synthetic Biology Market, by Product Type

  • 8.1. Biofertilizers
    • 8.1.1. Nitrogen Fixing
    • 8.1.2. Phosphate Solubilizing
    • 8.1.3. Potassium Mobilizing
  • 8.2. Biofuels
    • 8.2.1. Biodiesel
    • 8.2.2. Bioethanol
  • 8.3. Biomaterials
    • 8.3.1. Biofilms
    • 8.3.2. Bioplastics
  • 8.4. Biopesticides
    • 8.4.1. Biochemical
    • 8.4.2. Microbials
    • 8.4.3. Rnai Based
  • 8.5. Enzymes
    • 8.5.1. Amylases
    • 8.5.2. Cellulases
    • 8.5.3. Proteases

9. Agriculture Synthetic Biology Market, by Technology Platform

  • 9.1. Crispr/Cas
    • 9.1.1. Base Editing
    • 9.1.2. Cas12
    • 9.1.3. Cas9
  • 9.2. Metabolic Engineering
    • 9.2.1. Flux Analysis
    • 9.2.2. Pathway Optimization
  • 9.3. Rnai Interference
    • 9.3.1. Mirna
    • 9.3.2. Sirna
  • 9.4. Synthetic Pathways
    • 9.4.1. Modular Biosynthesis
    • 9.4.2. Pathway Assembly

10. Agriculture Synthetic Biology Market, by Formulation

  • 10.1. Encapsulated
    • 10.1.1. Microencapsulation
    • 10.1.2. Nanoencapsulation
  • 10.2. Liquid
    • 10.2.1. Aqueous
    • 10.2.2. Emulsions
  • 10.3. Powder
    • 10.3.1. Dry Granules
    • 10.3.2. Wettable Powders

11. Agriculture Synthetic Biology Market, by Application Area

  • 11.1. Animal Health
    • 11.1.1. Probiotics
    • 11.1.2. Therapeutic Proteins
  • 11.2. Crop Protection
    • 11.2.1. Disease Control
    • 11.2.2. Insect Control
    • 11.2.3. Weed Control
  • 11.3. Growth Enhancement
    • 11.3.1. Root Development
    • 11.3.2. Stress Tolerance
    • 11.3.3. Yield Improvement
  • 11.4. Soil Remediation
    • 11.4.1. Heavy Metal Removal
    • 11.4.2. Organic Pollutant Degradation

12. Agriculture Synthetic Biology Market, by End User

  • 12.1. Agri Biotech Companies
    • 12.1.1. Established
    • 12.1.2. Startups
  • 12.2. Commercial Farmers
    • 12.2.1. Large Scale
    • 12.2.2. Smallholder
  • 12.3. Research Institutions
    • 12.3.1. Government Labs
    • 12.3.2. University

13. Agriculture Synthetic Biology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Agriculture Synthetic Biology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Agriculture Synthetic Biology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Agriculture Synthetic Biology Market

17. China Agriculture Synthetic Biology Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AgBiome, Inc.
  • 18.6. Agragene, Inc.
  • 18.7. Arzeda Corporation
  • 18.8. BASF SE
  • 18.9. Bayer AG
  • 18.10. Benson Hill, Inc.
  • 18.11. BioConsortia, Inc.
  • 18.12. Calysta, Inc.
  • 18.13. Caribou Biosciences, Inc.
  • 18.14. Conagen Inc.
  • 18.15. Corteva, Inc.
  • 18.16. DuPont de Nemours, Inc.
  • 18.17. EVOLVE Biosystems, Inc.
  • 18.18. Ginkgo Bioworks, Inc.
  • 18.19. Inari Agriculture, Inc.
  • 18.20. Indigo Agriculture, Inc.
  • 18.21. KWS SAAT SE & Co. KGaA
  • 18.22. Limagrain Group
  • 18.23. Pairwise Companies, Inc.
  • 18.24. Pivot Bio, Inc.
  • 18.25. Syngenta AG
  • 18.26. Synthace Ltd.
  • 18.27. Zymergen Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NITROGEN FIXING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PHOSPHATE SOLUBILIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POTASSIUM MOBILIZING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIODIESEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOETHANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROBIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AMYLASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CELLULASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS12, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CAS9, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FLUX ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MODULAR BIOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PATHWAY ASSEMBLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY MICROENCAPSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY NANOENCAPSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AQUEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY EMULSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DRY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WETTABLE POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY THERAPEUTIC PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY DISEASE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY INSECT CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY WEED CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ROOT DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY HEAVY METAL REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ORGANIC POLLUTANT DEGRADATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ESTABLISHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY STARTUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LARGE SCALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SMALLHOLDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY UNIVERSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUELS, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOPESTICIDES, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CRISPR/CAS, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY METABOLIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RNAI INTERFERENCE, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC PATHWAYS, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ENCAPSULATED, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY CROP PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY GROWTH ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SOIL REMEDIATION, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY AGRI BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY COMMERCIAL FARMERS, 2018-2032 (USD MILLION)
  • TABLE 290. LATIN AMERICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFERTILIZERS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA AGRICULTURE SYNTHETIC BIOLOG